-
Most Popular

Biotech Stocks
Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

3 Promising Biotech Stocks for the Long-Term: August 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.

The 3 Best Healthcare Stocks to Buy in August 2024
These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.
Recent Biotech Stocks Articles
Blockbuster Clinical Results Shine a Positive Light on Sunshine Biopharma
An SEC filing may have deterred some traders from holding SBFM stock. However, a closer look at the facts should clear up any confusion.
Cassava Sciences Just Returned to the Buy Zone
There's no need to panic about SAVA stock, as Cassava Sciences just launched an important study focused on treating Alzheimer's disease.
4 New Patents Add to Progenity’s Appeal
PROG stock has had its fair share of ups and downs. With a major executive-level change, however, Progenity looked poised for progress.
With Progress on Multiple Fronts, Bionano Genomics Stock Is Great Buy Here
Bionano's acquisition of a software company makes Saphyr more attractive, and studies should result in insurers reimbursing those who use the system. BNGO stock is a buy.
The 3 Biotech Firms Riding High on CRISPR News
Biotech stocks can be risky. If a clinical trial fails, you could very well lose your money. But choose wisely, and they can take off.
4 Stocks to Boost Your Portfolio (In an Unintuitive Way)
Moonshot investing can be risky, that's for sure. But if you learn from the mistakes of past moonshots, you can minimize your own.
The Story of 2020 … and Possibly 2021 … and What it Means for Your Investments
In the not-too-distant future, healthcare will look dramatically different from what we know today. From telemedicine to precision medicine to genetic therapy, the global healthcare industry is about to be shaken up like never before.
With Pfizer Partnership, BioNTech Stock Should Push Higher
In light of a collaboration with a major drugmaker and a fast-track toward possible FDA approval, BNTX stock is practically irresistible.
Volatility May Continue, But CRISPR Stock Remains a Buy
Even after rebounding in recent weeks, consider now (or any pullback) prime time to enter a long-term position in CRISPR stock.
Repligen Stock: This Little-Known Biotech Posts Record Results
Repligen stock jumped 9% on the heels of the report to a new 52-week high of $203.90 today. And Louis Navellier sees a lot more upside for the company. Here's what potential RGEN stock investors should know.
Which Biotech Stocks Are a Buy on Earnings?
If you’re interested in high-growth biotech stocks with superior fundamentals, here are which ones to consider, and which ones to skip.
A New Healthcare Stock Pick in the Industry of the Decade
This company is riding a powerful trend in the future of healthcare. Plus, it offers high growth, a huge potential market and a path to profitability.
Biotech Boom: The Race for COVID-19 Vaccines
The pandemic highlights how far medical science has come. It also highlights how exciting the future is. While the Year of Biotech has been outstanding so far, we’re only seeing the beginning of a revolution.